Watchlist Price Alert

Fusion Pharmaceuticals In... (FUSN)

NASDAQ: FUSN · Real-Time Price · USD

21.55

0.03 (0.14%)

At close: Jun 03, 2024, 8:00 PM

Fusion Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-94.9M	-87.61M	-81.05M	-78.33M	-16.19M	-11.65M	-6.26M
Depreciation & Amortization	1.34M	909K	634K	482K	290K	114K	23K
Stock-Based Compensation	12.44M	10.84M	8.6M	3.37M	618K	n/a	112K
Other Working Capital	-650K	2.96M	-962K	3.18M	2.61M	-191K	114K
Other Non-Cash Items	-222K	2.08M	11.66M	39.56M	-1.44M	1.71M	-733K
Deferred Income Tax	845K	-3.16M	-991K	-576K	-59K	-19K	34K
Change in Working Capital	-1.32M	3.66M	-14.6M	5.74M	3.08M	-572K	703K
Operating Cash Flow	-81.8M	-73.28M	-75.74M	-29.77M	-13.69M	-9.87M	-6.13M
Capital Expenditures	-3.89M	-2.14M	-1.49M	-1.12M	-456K	-1.12M	-96K
Cash Acquisitions	38.87M	-25.23M	-39.27M	-9.7M	n/a	n/a	n/a
Purchase of Investments	-230.57M	-165.16M	-172.47M	-219.03M	n/a	n/a	n/a
Sales Maturities Of Investments	191.7M	190.38M	211.73M	9.7M	n/a	n/a	n/a
Other Investing Acitivies	-38.87M	25.23M	39.27M	9.7M	n/a	n/a	n/a
Investing Cash Flow	-42.76M	23.09M	37.77M	-210.45M	-456K	-1.12M	-96K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	1.28M	n/a	-72.4M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	142.01M	40.73M	347K	265.51M	52.19M	18.37M	27.17M
Financial Cash Flow	142.01M	40.73M	347K	265.51M	52.19M	18.37M	27.17M
Net Cash Flow	17.61M	-9.46M	-37.62M	25.29M	38.04M	7.38M	20.95M
Free Cash Flow	-85.69M	-75.42M	-77.23M	-30.89M	-14.15M	-10.99M	-6.22M